FindTrial
Sign In

Factors predicting the high diagnostic yield of EUS–guided fine needle aspiration and biopsy in solid pancreatic mass: prospective study for optimal number of needle passes and other influencing factors

Factors predicting the high diagnostic yield of EUS–guided fine needle aspiration and biopsy in solid pancreatic mass: prospective study for optimal number of needle passes and other influencing factors

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0001735
Enrollment
120
Registered
2015-12-17
Start date
2015-10-26
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Gachon University Gil Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with pancretic mass lesion who need to EUS-FNA for diagnosis will be recruited for study

Exclusion criteria

Exclusion criteria: Patients with pancretic cystic lesion who need to EUS-FNA for diagnosis will be recruited for study, patient < 18 years, patients who underwent gastrectomy previously, hemodynamic unstable patient, a pregnant patient, patient who do not agree to informed consent, patient who do not want to enroll the study

Design outcomes

Primary

MeasureTime frame
Factors predicting the high diagnostic yield of EUS–guided fine needle aspiration and biopsy in pancreatic mass lesion—

Secondary

MeasureTime frame
Optimal number of needle passes predicting the high diagnostic yield of EUS–guided fine needle aspiration and biopsy in pancreatic mass lesion—

Countries

Korea, Republic of

Contacts

Public ContactSeok Jeong

Gachon University Gil Medical Center

ssukoo@naver.com+82-32-460-3778

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026